Commune with Jeff Krasno cover image

The Science of Metabolic Health with Dr. Ben Bikman

Commune with Jeff Krasno

00:00

How GLP-1 drugs like semaglutide work and risks

Ben reviews semaglutide's glucagon inhibition, gut motility risks, and potential fat-cell rebound after stopping.

Play episode from 01:09:44
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app